An EQ-5D-5L value set based on Uruguayan population preferences

Quality of Life Research

Volumn 25, Issue 2, 2016, Pages 323-333

  Augustovski, Federico ^a,b   Rey Ares, Lucila ^a   Irazola, Vilma ^a   Garay, Osvaldo Ulises ^a   Gianneo, Oscar ^c   Fernández, Graciela ^c   Morales, Marcelo ^c   Gibbons, Luz ^a   Ramos Goñi, Juan Manuel ^d,e  

^a INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Fondo Nacional de Recursos   (Uruguay)

^d EuroQol Research Foundation   (Netherlands)

^e Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas REDISSEC   (Spain)

Author keywords

EuroQol; Preferences; Quality of life; Uruguay; Value set

Indexed keywords

ADULT; AGE; AGED; ANXIETY; ARGENTINIAN; ARTICLE; DEPRESSION; EDUCATIONAL STATUS; EQ 5D 5L QUESTIONNAIRE; FEMALE; HEALTH LITERACY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; SELF CARE; SEX DIFFERENCE; SOCIAL STATUS; URUGUAY; URUGUAYAN; VISUAL ANALOG SCALE; MIDDLE AGED; REFERENCE VALUE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; REFERENCE VALUES; SURVEYS AND QUESTIONNAIRES; URUGUAY; YOUNG ADULT;

EID: 84955402141     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-015-1086-4     Document Type: Article

References (34)

1. Hawthorne, G., Richardson, J., & Day, N. A. (2001). A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Annals of Medicine,33(5), 358–370.
2. Brauer, C. A., Rosen, A. B., Greenberg, D., & Neumann, P. J. (2006). Trends in the measurement of health utilities in published cost-utility analyses. Value Health,9(4), 213–218.
3. Guide to the methods of technology appraisal 2013. (2013). Process and methods guides. National Institute for Heatlh and Care Excellence (NICE): UK.
4. Szende, A., Oppe, M., & Devlin, N. (2007). EQ-5D value sets: Inventory, comparative review and user guide (Vol. 2). Dordrecht: Springer.
5. Augustovski, F. A., Irazola, V. E., Velazquez, A. P., Gibbons, L., & Craig, B. M. (2009). Argentine valuation of the EQ-5D health states. Value Health,12(4), 587–596.
6. Zarate, V., Kind, P., Valenzuela, P., Vignau, A., Olivares-Tirado, P., & Munoz, A. (2011). Social valuation of EQ-5D health states: The Chilean case. Value Health,14(8), 1135–1141.
7. Viegas Andrade, M., Noronha, K., Kind, P., Maia, A. C., Miranda de Menezes, R., De Barros Reis, C., et al. (2013). Societal preferences for EQ-5D health states from a Brazilian population survey. Value in Health Regional Issues,2(3), 405–412.
8. EuroQol, G. (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy,16(3), 199–208.
9. Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research,20(10), 1727–1736.
10. Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health Qual Life Outcomes,13(1), 14.
11. Golicki, D., Niewada, M., Buczek, J., Karlinska, A., Kobayashi, A., Janssen, M. F., & Pickard, A. S. (2015). Validity of EQ-5D-5L in stroke. Quality of Life Research,24(4), 845–850.
12. Conner-Spady, B. L., Marshall, D. A., Bohm, E., Dunbar, M. J., Loucks, L., Khudairy, A. A., & Noseworthy, T. W. (2015). Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement. Quality of Life Research, 24(7), 1775–1784.
13. Greene, M. E., Rader, K. A., Garellick, G., Malchau, H., Freiberg, A. A., & Rolfson, O. (2014). The EQ-5D-5L Improves on the EQ-5D-3L for health-related quality-of-life assessment in patients undergoing total hip arthroplasty. Clinical Orthopaedics and Related Research. doi:10.1007/s11999-014-4091-y.
14. Oppe, M., Devlin, N. J., van Hout, B., Krabbe, P. F., & de Charro, F. (2014). A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health,17(4), 445–453.
15. EuroQol Valuation Technology. (2011). Retrieved January, 2015, from https://www.valuationstudy.org.
16. Censo. (2011). Retrieved September 2014, from http://www.ine.gub.uy/censos2011/index.html.
17. Modificación de la integración de la comisión asesora del Formulario Terapéutico Nacional. (2010). Decreto N 04/010 (2010th ed.). Montevideo: Presidencia República Oriental del Uruguay.
18. Fondo Nacional de Recursos. Retrieved January 2015, from http://www.fnr.gub.uy.
19. Devlin, N. J., & Krabbe, P. F. (2013). The development of new research methods for the valuation of EQ-5D-5L. The European Journal of Health Economics,14(Suppl 1), S1–S3.
20. Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care,35(11), 1095–1108.
21. Tilling, C., Devlin, N., Tsuchiya, A., & Buckingham, K. (2010). Protocols for time tradeoff valuations of health states worse than dead: A literature review. Medical Decision Making,30(5), 610–619.
22. Lamers, L. M. (2007). The transformation of utilities for health states worse than death: Consequences for the estimation of EQ-5D value sets. Medical Care,45(3), 238–244.
23. Augustovski, F., Rey-Ares, L., Irazola, V., Oppe, M., & Devlin, N. J. (2013). Lead versus lag-time trade-off variants: Does it make any difference? The European Journal of Health Economics,14(Suppl 1), S25–S31.
24. Janssen, B. M., Oppe, M., Versteegh, M. M., & Stolk, E. A. (2013). Introducing the composite time trade-off: A test of feasibility and face validity. European Journal of Health Economics,14(Suppl 1), S5–S13.
25. Krabbe, P. F., Devlin, N. J., Stolk, E. A., Shah, K. K., Oppe, M., van Hout, B., et al. (2014). Multinational evidence of the applicability and robustness of discrete choice modeling for deriving EQ-5D-5L health-state values. Medical Care,52(11), 935–943.
26. Ramos-Goni, J. M., Rivero-Arias, O., Errea, M., Stolk, E. A., Herdman, M., & Cabases, J. M. (2013). Dealing with the health state ‘dead’ when using discrete choice experiments to obtain values for EQ-5D-5L heath states. European Journal of Health Economics,14(Suppl 1), S33–S42.
27. Ramos-Goni, J. M., Pinto-Prades, J. L., Oppe, M., Cabases, J. M., Serrano-Aguilar, P., & Rivero-Arias, O. (2014). Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Medical Care. doi:10.1097/MLR.0000000000000283.
28. Lee, S. Y., Stucky, B. D., Lee, J. Y., Rozier, R. G., & Bender, D. E. (2010). Short assessment of health literacy-Spanish and English: A comparable test of health literacy for Spanish and English speakers. Health Services Research,45(4), 1105–1120.
29. Selden, C. R., Zorn, M., Ratzan, S. C., & Parker, R. M. (2000). Health literacy, current bibliographies in medicine. Bethesda, MD: National Institutes of Health.
30. Huber, P. J. (1964). Robust estimation of a location parameter. The Annals of Mathematical Statistics, 35(1), 73–101.
31. Hamilton, L. (1991). srd1: How robust is robust regression? Stata Technical Bulletin Reprints,1, 169–175.
32. EQ-5D-5L Crosswalk value sets. Retrieved January 2015, from http://www.euroqol.org/about-eq-5d/valuation-of-eq-5d/eq-5d-5l-value-sets.html.
33. van Hout, B., Janssen, M. F., Feng, Y. S., Kohlmann, T., Busschbach, J., Golicki, D., et al. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health,15(5), 708–715.
34. Szende, A., Janssen, B. M., & Cabasés, J. M. (2014). Self-reported population health: An international perspective based on EQ-5D. Dordrecht, Heidelberg, New York, London: Springer.